(Q34505429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

5

Susan van den Hof

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

3

Susan Hahné

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

Hester de Melker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Guy Berbers

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hans Rümke

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hein Boot

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

24 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

3946-3952

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16564115%20AND%20SRC:MED&resulttype=core&format=json

Varicella zoster virus vaccination policies and surveillance strategies in Europe.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Consensus: varicella vaccination of healthy children--a challenge for Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Non-participation in a population-based seroprevalence study of vaccine-preventable diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

The seroepidemiology and transmission dynamics of varicella in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

The seroepidemiology of varicella in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Estimated varicella incidence on the basis of a seroprevalence survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Seroprevalence of varicella-zoster virus in the German population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

The incidence of chickenpox in the community. Lessons for disease surveillance in sentinel practice networks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

The burden of severe varicella in Spain, 1995--2000 period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Prevalence of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis A viruses among Spanish adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

The incidence of shingles and its implications for vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

Economic evaluations of varicella vaccination programmes: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.017